Pediatric cannabis edible exposures jumped 5-fold after dispensaries opened in Massachusetts

Among 32 children seen at one hospital for cannabis edible ingestion, there was a 5-fold increase after recreational dispensaries opened, with younger children more likely to need respiratory support and hospitalization.

Kaczor, Eric E et al.·Journal of medical toxicology : official journal of the American College of Medical Toxicology·2021·Preliminary EvidenceRetrospective Cohort
RTHC-03229Retrospective CohortPreliminary Evidence2021RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Retrospective Cohort
Evidence
Preliminary Evidence
Sample
N=32

What This Study Found

Pediatric edible cannabis exposures increased five-fold after Massachusetts recreational dispensaries opened. Age under 10 was associated with bradypnea, hypertension, hospital admission, and need for respiratory support. Overall, 16% required respiratory support and 34% required hospital admission. Respiratory support was associated with lethargy, bradypnea, hypercarbia, seizure, and hypertension.

Key Numbers

32 cases. 5-fold increase after dispensaries opened. 16% needed respiratory support. 34% required hospitalization. Age <10 associated with bradypnea, hypertension, admission, and respiratory support.

How They Did This

Retrospective chart review at a single tertiary care academic medical center covering a 28-month period. Included children under 18 evaluated in the ED for edible cannabis exposure without co-ingestion of other substances. 32 cases identified.

Why This Research Matters

Edible cannabis products are particularly dangerous for young children because they are often packaged in appealing forms (gummies, chocolates) and can cause more severe effects than inhalation due to delayed onset and higher bioavailability. The 5-fold increase after dispensary opening suggests a direct policy consequence.

The Bigger Picture

As more states legalize recreational cannabis, the pediatric safety of edible products becomes a growing public health concern. Child-resistant packaging and public awareness about keeping edibles out of children's reach are critical harm reduction measures.

What This Study Doesn't Tell Us

Single center, small sample (32 cases). No THC dose quantification. Cannot determine true population incidence. Retrospective design may miss cases not presenting to this hospital.

Questions This Raises

  • ?Are child-resistant packaging requirements reducing pediatric exposures?
  • ?What is the relationship between THC dose and severity in children?
  • ?Would mandatory labeling changes reduce accidental ingestions?

Trust & Context

Key Stat:
5-fold increase in pediatric edible exposures after dispensaries opened
Evidence Grade:
Small single-center retrospective study. Preliminary but highlights an important safety signal.
Study Age:
2021 study from Massachusetts covering the period around recreational dispensary opening.
Original Title:
Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes.
Published In:
Journal of medical toxicology : official journal of the American College of Medical Toxicology, 17(4), 386-396 (2021)
Database ID:
RTHC-03229

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-ControlFollows or compares groups over time
This study
Cross-Sectional / Observational
Case Report / Animal Study

Looks back at existing records to find patterns.

What do these levels mean? →

Frequently Asked Questions

How dangerous are cannabis edibles for children?

In this study, 16% of children needed breathing support and 34% were hospitalized. Younger children (under 10) were at higher risk for serious symptoms including respiratory depression and seizures.

Did legalization increase pediatric exposures?

Yes. There was a 5-fold increase in pediatric edible cannabis exposures after recreational dispensaries opened in Massachusetts.

Read More on RethinkTHC

Cite This Study

RTHC-03229·https://rethinkthc.com/research/RTHC-03229

APA

Kaczor, Eric E; Mathews, Bonnie; LaBarge, Kara; Chapman, Brittany P; Carreiro, Stephanie. (2021). Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes.. Journal of medical toxicology : official journal of the American College of Medical Toxicology, 17(4), 386-396. https://doi.org/10.1007/s13181-021-00849-0

MLA

Kaczor, Eric E, et al. "Cannabis Product Ingestions in Pediatric Patients: Ranges of Exposure, Effects, and Outcomes.." Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2021. https://doi.org/10.1007/s13181-021-00849-0

RethinkTHC

RethinkTHC Research Database. "Cannabis Product Ingestions in Pediatric Patients: Ranges of..." RTHC-03229. Retrieved from https://rethinkthc.com/research/kaczor-2021-cannabis-product-ingestions-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.